Glu-Gly-Cit

Glu-Gly-Cit is a tripeptide sequence that specifically responds to fibrinolysin, an enzyme commonly overexpressed in the tumor microenvironment. As an enzymatic cleavage linker, it can be utilized to construct antibody-drug conjugates and prodrug systems, enabling targeted release of cytotoxic drugs at the lesion site. This approach significantly enhances therapeutic precision while reducing systemic toxicity.

Similar Products: Gly-Gly, Val-Gly, Val-Cit, Enzyme-Cleavable Val-Cit.